PharmX Technologies (PHX) Financial Statements

2 Followers

PharmX Technologies Financial Overview

PharmX Technologies's market cap is currently AU$69.94M. The company's EPS TTM is AU$-0.0016; its P/E ratio is -250.00; PharmX Technologies is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 25	Jun 24
Income Statement
Total Revenue	AU$ 7.62M	AU$ 7.32M
Gross Profit	AU$ -70.00K	AU$ 5.96M
Operating Income	AU$ -2.09M	AU$ -1.42M
EBITDA	AU$ -532.00K	AU$ 1.39M
Net Income	AU$ -1.83M	AU$ -264.00K
Balance Sheet
Cash & Short-Term Investments	AU$ 2.57M	AU$ 4.17M
Total Assets	AU$ 27.27M	AU$ 18.82M
Total Debt	AU$ 540.00K	AU$ 894.00K
Net Debt	AU$ -2.03M	AU$ -3.28M
Total Liabilities	AU$ 3.99M	AU$ 2.90M
Stockholders' Equity	AU$ 23.28M	AU$ 15.93M
Cash Flow
Free Cash Flow	AU$ 805.00K	AU$ -8.16M
Operating Cash Flow	AU$ 825.00K	AU$ -8.13M
Investing Cash Flow	AU$ -2.10M	AU$ -695.00K
Financing Cash Flow	AU$ -322.00K	AU$ -136.00K

Currency in AUD

PharmX Technologies Earnings and Revenue History

Income Statement >

PharmX Technologies Debt to Assets

Balance Sheet >

PharmX Technologies Cash Flow

Cash Flow >

PharmX Technologies Forecast EPS vs Actual EPS

Earnings >